Polivy 140 mg

Polatuzumab vedotin 140 mg is a powder for solution used in intravenous therapy. This medication is designed to target specific cells in the body, often used in cancer treatment protocols.

Polatuzumab vedotin is primarily used in the treatment of certain types of cancer. It works by targeting specific cells, which may help in reducing the growth of cancerous cells. This medication is often used in combination with other treatments to manage cancer. What is polatuzumab vedotin used for? It is typically used for conditions where targeted therapy is beneficial, such as in lymphoma treatment.

Common effects of polatuzumab vedotin may include fatigue, nausea, and low blood cell counts. Some individuals may experience infusion-related reactions. These effects can vary from person to person and may not affect everyone who uses this medication.

Polatuzumab vedotin should be handled with care and administered by healthcare professionals. It is important to follow the prescribed guidelines for use. Patients should be monitored for any adverse reactions. This medication should not be used without medical supervision.

Polatuzumab vedotin may interact with other medications, including those that affect the immune system. It is important to inform healthcare providers about all medications being taken. Alcohol and certain foods may also interact with this medication, so it is advisable to discuss dietary and lifestyle habits with a healthcare professional.